Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

NCT00403234 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped due to administrative reasons not related to efficacy or safety.

Conditions

Postoperative Pain

Interventions

DRUG: Buprenorphine transdermal patch
DRUG: Buprenorphine transdermal patch
DRUG: Buprenorphine transdermal patch
DRUG: Placebo BTDS

Sponsor

Purdue Pharma LP